Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Recruiting
Observational Study
Neonatal Thrombocytopenia
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 0 Days – 6 Months
- Sex
- Any
- Study type
- Observational
- Participants needed
- 160 (estimated)
- Sponsor
- Boston Children's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective observational study that was designed with the following two Specific Aims:
1. To determine whether the Immature Platelet Fraction percentage (IPF%) and the Immature Platelet Count (IPC) are better predictors of bleeding than the platelet count alone in neonates of different gestational and post-conceptional ages and with different etiologies of thrombocytopenia; and
2. To c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Have a post-menstrual age between 23 and 44 weeks;
2. Have a PLT count \<100 x 109/L; and
3. Have a parent/guardian willing to provide written informed consent.
Exclusion Criteria:
1. Are not expected to survive for \>5 days by the Attending Neonatologist;
2. Are thought to…
Contacts